Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | ITGAV | P06756 | 3/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.43 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.43 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.43 |
| ▸ | ITGA2 | P17301 | 1/20 | 0.41 |
| ▸ | BMP1 | P13497 | 4/20 | 0.41 |
| ▸ | NPY4R | P50391 | 2/20 | 0.41 |
| ▸ | NPY1R | P25929 | 1/20 | 0.41 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.40 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27412426 | 1.00 | RECQL (0.47) | RECQLITGAVPOLBSLC1A3SLC1A2 | |
| SCHEMBL8013936 | 0.90 | ITGAV (0.49) | ITGAVSLC1A3SLC1A2SLC1A1ITGA2 | |
| SCHEMBL6877985 | 0.89 | ITGAV (0.57) | ITGAVSLC1A3SLC1A2SLC1A1ITGA2 | |
| SCHEMBL8492995 | 0.89 | ITGAV (0.57) | ITGAVSLC1A3SLC1A2SLC1A1ITGA2 | |
| SCHEMBL27734963 | 0.85 | BMP1 (0.52) | BMP1ITGB3ITGA2B | |
| SCHEMBL11207292 | 0.83 | RECQL (0.52) | RECQLITGAVPOLBSLC1A3SLC1A2 | |
| Methyl P-Toluenesulfonyl-L-Argininate SCHEMBL324561 | 0.82 | ITGB3 (0.57) | BMP1ITGB3ITGA2B | |
| Methyl P-Toluenesulfonyl-L-Argininate SCHEMBL2853451 | 0.82 | ITGB3 (0.57) | BMP1ITGB3ITGA2B | |
| Methyl P-Toluenesulfonyl-L-Argininate SCHEMBL1034821 | 0.81 | ITGB3 (0.56) | BMP1ITGB3ITGA2B | |
| Methyl P-Toluenesulfonyl-L-Argininate SCHEMBL11880215 | 0.81 | ITGB3 (0.56) | BMP1ITGB3ITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2588128-A1 | LACTOFERRIN SEQUENCES, COMPOSITIONS AND METHODS OF CORNEAL WOUND TREATMENT | Brien Holden Vision Institute (AU) | 2013-05-08 | — | — | EP | disclosed |
| WO-2012000054-A1 | LACTOFERRIN SEQUENCES, COMPOSITIONS AND METHODS OF CORNEAL WOUND TREATMENT | BRIEN HOLDEN VISION INSTITUTE (AU) | 2012-01-05 | — | — | WO | disclosed |
| EP-2144625-A1 | A CONTROLLED RELEASE ENZYMATIC COMPOSITION AND METHODS OF USE | Arcimboldo AB (SE) | 2010-01-20 | — | — | EP | disclosed |
| WO-2008070698-A1 | A CONTROLLED RELEASE ENZYMATIC COMPOSITION AND METHODS OF USE | ARCIMBOLDO AB (SE) | 2008-06-12 | — | — | WO | disclosed |
| US-20010024816-A1 | TNF-alpha converting enzyme | BLACK ROY A (US) | 2001-09-27 | — | — | US | disclosed |